Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 103641148 | 10364114 | 8 | F | 201406 | 20160823 | 20140806 | 20160829 | EXP | CA-ROCHE-1445366 | ROCHE | 54.64 | YR | F | Y | 0.00000 | 20160829 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 103641148 | 10364114 | 1 | PS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0062,S0003B | 103976 | 225 | MG | SOLUTION FOR INJECTION | QOW | |||||
| 103641148 | 10364114 | 2 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0062,S0003B | 103976 | SOLUTION FOR INJECTION | ||||||||
| 103641148 | 10364114 | 3 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0062,S0003B | 103976 | SOLUTION FOR INJECTION | ||||||||
| 103641148 | 10364114 | 4 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0062,S0003B | 103976 | SOLUTION FOR INJECTION | ||||||||
| 103641148 | 10364114 | 5 | C | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Unknown | 200/6 OT | 0 | BID | |||||||||
| 103641148 | 10364114 | 6 | C | VENTOLIN | ALBUTEROL SULFATE | 1 | 0 | ||||||||||||
| 103641148 | 10364114 | 7 | C | GUAIFENESIN. | GUAIFENESIN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 103641148 | 10364114 | 1 | Asthma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 103641148 | 10364114 | OT |
| 103641148 | 10364114 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 103641148 | 10364114 | Acute sinusitis | |
| 103641148 | 10364114 | Ankle fracture | |
| 103641148 | 10364114 | Asthma | |
| 103641148 | 10364114 | Atelectasis | |
| 103641148 | 10364114 | Blood pressure increased | |
| 103641148 | 10364114 | Bronchitis | |
| 103641148 | 10364114 | Cough | |
| 103641148 | 10364114 | Fall | |
| 103641148 | 10364114 | Lymphadenopathy | |
| 103641148 | 10364114 | Nasal oedema | |
| 103641148 | 10364114 | Nasal polyps | |
| 103641148 | 10364114 | Productive cough | |
| 103641148 | 10364114 | Respiratory tract infection | |
| 103641148 | 10364114 | Tendonitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 103641148 | 10364114 | 1 | 20131031 | 0 | ||
| 103641148 | 10364114 | 2 | 20151223 | 0 | ||
| 103641148 | 10364114 | 3 | 20160303 | 0 | ||
| 103641148 | 10364114 | 4 | 20160810 | 0 |